Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes

Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes

Bax, H., Chauhan, J., Stavraka, C., Santaolalla, A., Osborn, G., Khiabany, A., Grandits, M., Lopez-Abente Muroz, J., Gusmao Ferreira, L. C., Chan Wah Hak, C., Robinson, A., Pope, A., Woodman, N., Naceur-Lombardelli, C., Malas, S., Nakamura, M., Coumbe, J. E. M., Laddach, R., Mele, S. & Crescioli, S. & 16 others, Black, A., Lombardi, S., Canevari, S., Figini, M., Sayasneh, A., Tsoka, S., FitzGerald, K., Gillett, C., Pinder, S., Van Hemelrijck, M., Kristeleit, R., Ghosh, S., Montes, A., Spicer, J., Karagiannis, S. N. & Josephs, D., 19 Nov 2022, (E-pub ahead of print) In: British Journal of Cancer. 128, p. 342-353 12 p., https://doi.org/10.1038/s41416-022-02031-x.

Research output: Contribution to journal › Article › peer-review